88 related articles for article (PubMed ID: 23415943)
1. Microbial synthesis of poly-3-hydroxybutyrate and its application as targeted drug delivery vehicle.
Althuri A; Mathew J; Sindhu R; Banerjee R; Pandey A; Binod P
Bioresour Technol; 2013 Oct; 145():290-6. PubMed ID: 23415943
[TBL] [Abstract][Full Text] [Related]
2. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate.
Kim SH; Jeong JH; Chun KW; Park TG
Langmuir; 2005 Sep; 21(19):8852-7. PubMed ID: 16142970
[TBL] [Abstract][Full Text] [Related]
3. Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide.
Chen H; Ahn R; Van den Bossche J; Thompson DH; O'Halloran TV
Mol Cancer Ther; 2009 Jul; 8(7):1955-63. PubMed ID: 19567824
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy.
Kılıçay E; Demirbilek M; Türk M; Güven E; Hazer B; Denkbas EB
Eur J Pharm Sci; 2011 Oct; 44(3):310-20. PubMed ID: 21884788
[TBL] [Abstract][Full Text] [Related]
5. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
[TBL] [Abstract][Full Text] [Related]
6. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs.
Park EK; Lee SB; Lee YM
Biomaterials; 2005 Mar; 26(9):1053-61. PubMed ID: 15369694
[TBL] [Abstract][Full Text] [Related]
8. Using targeted magnetic arsenic trioxide nanoparticles for osteosarcoma treatment.
Li XS; Li WQ; Wang WB
Cancer Biother Radiopharm; 2007 Dec; 22(6):772-8. PubMed ID: 18158768
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel folate conjugated fluorescent nanoparticles for tumor imaging.
Hou J; Zhang Q; Li X; Tang Y; Cao MR; Bai F; Shi Q; Yang CH; Kong DL; Bai G
J Biomed Mater Res A; 2011 Dec; 99(4):684-9. PubMed ID: 21913319
[TBL] [Abstract][Full Text] [Related]
10. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery.
Guo M; Que C; Wang C; Liu X; Yan H; Liu K
Biomaterials; 2011 Jan; 32(1):185-94. PubMed ID: 21067808
[TBL] [Abstract][Full Text] [Related]
12. Folate-functionalized nanoparticles for controlled 5-Fluorouracil delivery.
Zhang Y; Li J; Lang M; Tang X; Li L; Shen X
J Colloid Interface Sci; 2011 Feb; 354(1):202-9. PubMed ID: 21094493
[TBL] [Abstract][Full Text] [Related]
13. Folate-conjugated methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery.
Park EK; Kim SY; Lee SB; Lee YM
J Control Release; 2005 Dec; 109(1-3):158-68. PubMed ID: 16263189
[TBL] [Abstract][Full Text] [Related]
14. In vitro release behavior and cytotoxicity of doxorubicin-loaded gold nanoparticles in cancerous cells.
Asadishad B; Vossoughi M; Alamzadeh I
Biotechnol Lett; 2010 May; 32(5):649-54. PubMed ID: 20131082
[TBL] [Abstract][Full Text] [Related]
15. Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer.
Saxena V; Naguib Y; Hussain MD
Colloids Surf B Biointerfaces; 2012 Jun; 94():274-80. PubMed ID: 22377218
[TBL] [Abstract][Full Text] [Related]
16. Targeting of nanoparticles: folate receptor.
Kularatne SA; Low PS
Methods Mol Biol; 2010; 624():249-65. PubMed ID: 20217601
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization, and in vivo evaluation of mitoxantrone-loaded, folate-conjugated albumin nanoparticles.
Zhang LK; Hou SX; Zhang JQ; Hu WJ; Wang CY
Arch Pharm Res; 2010 Aug; 33(8):1193-8. PubMed ID: 20803122
[TBL] [Abstract][Full Text] [Related]
18. Tumor-specific hybrid polyhydroxybutyrate nanoparticle: surface modification of nanoparticle by enzymatically synthesized functional block copolymer.
Lee J; Jung SG; Park CS; Kim HY; Batt CA; Kim YR
Bioorg Med Chem Lett; 2011 May; 21(10):2941-4. PubMed ID: 21489794
[TBL] [Abstract][Full Text] [Related]
19. Folate targeted polymeric 'green' nanotherapy for cancer.
Narayanan S; Binulal NS; Mony U; Manzoor K; Nair S; Menon D
Nanotechnology; 2010 Jul; 21(28):285107. PubMed ID: 20585151
[TBL] [Abstract][Full Text] [Related]
20. 9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: preparation and evaluation in vitro.
Han X; Liu J; Liu M; Xie C; Zhan C; Gu B; Liu Y; Feng L; Lu W
Int J Pharm; 2009 May; 372(1-2):125-31. PubMed ID: 19166923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]